FDA Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anthrax Vaccines
New findings in anthrax vaccines described from Naval Institute for Dental and Biomedical Research
March 15th, 2007
Research findings, "The impact of incomplete vaccination schedules on the magnitude and duration of protective antigen-specific IgG responses in recipients of the US licensed anthrax vaccine," are discussed in a new report. "Using a cross-sectional analysis design, we measured serum anti-protective antigen (PA) concentrations in individuals receiving six or fewer US licensed anthrax vaccinations. Samples were collected from 363 individuals with a mean of 29.6±8.42 months after their last vaccination (range 3-57 months)," scientists writing in the journal Vaccine report. "An enzyme-linked immunosorbent assay (ELISA) developed and validated by the Centers...
Source: FDA Law Weekly (2007-03-15)
|
